SUNLENCA

gilead sciences canada inc🇨🇦 Health Canada

Approval Id: 322824ea452ab99b
Drug Approval Canada Name: SUNLENCA
Product Name: SUNLENCA
Status: Marketed
Status Date: 2023-03-15
Original Market Date: 2023-03-15
Din: 02532468
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.92
Atc Original: J05AX31 LENACAPAVIR
Atc Name: j 05 ax 31
Aig Number: 0164221001
Company Name: gilead sciences canada inc
Company Address: 400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2

LENACAPAVIR (LENACAPAVIR SODIUM)

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

322824ea452ab99b

Type

Standard